Core Laboratories NV

Established an at-the-market equity offering program under which it may, from time to time, sell its common shares having an aggregate sales price of up to $60 million, and has entered into an equity distribution agreement with Wells Fargo Securities LLC as sales agent. Proceeds will be used for general corporate purposes, which may include, among other things, investments in the development of new products and technology, capex, repayments of indebtedness, working capital and potential acquisitions. Pending these uses, proceeds will be used for investments in investment-grade interest-bearing obligations, highly liquid cash equivalents, certificates of deposit, or direct or guaranteed obligations of the U.S.